Victory Capital Management’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.77M Buy
51,830
+16,714
+48% +$892K ﹤0.01% 1500
2025
Q1
$1.42M Buy
35,116
+27,881
+385% +$1.13M ﹤0.01% 1642
2024
Q4
$201K Sell
7,235
-135
-2% -$3.76K ﹤0.01% 2235
2024
Q3
$211K Buy
+7,370
New +$211K ﹤0.01% 2214
2024
Q1
Sell
-13,880
Closed -$324K 2476
2023
Q4
$324K Sell
13,880
-179,572
-93% -$4.19M ﹤0.01% 2104
2023
Q3
$9.78M Sell
193,452
-104,120
-35% -$5.27M 0.01% 1027
2023
Q2
$13.9M Buy
297,572
+93,990
+46% +$4.39M 0.02% 913
2023
Q1
$7.79M Buy
203,582
+199,495
+4,881% +$7.63M 0.01% 1101
2022
Q4
$224K Sell
4,087
-15,127
-79% -$829K ﹤0.01% 2243
2022
Q3
$654K Sell
19,214
-702
-4% -$23.9K ﹤0.01% 1929
2022
Q2
$188K Sell
19,916
-10
-0.1% -$94 ﹤0.01% 2365
2022
Q1
$209K Buy
19,926
+717
+4% +$7.52K ﹤0.01% 2398
2021
Q4
$406K Sell
19,209
-2,763
-13% -$58.4K ﹤0.01% 2259
2021
Q3
$491K Buy
21,972
+31
+0.1% +$693 ﹤0.01% 2184
2021
Q2
$544K Sell
21,941
-1,021
-4% -$25.3K ﹤0.01% 2164
2021
Q1
$666K Sell
22,962
-1,058
-4% -$30.7K ﹤0.01% 2072
2020
Q4
$620K Sell
24,020
-1,022
-4% -$26.4K ﹤0.01% 1973
2020
Q3
$771K Sell
25,042
-8,666
-26% -$267K ﹤0.01% 1816
2020
Q2
$840K Sell
33,708
-34,180
-50% -$852K ﹤0.01% 1806
2020
Q1
$1.44M Buy
67,888
+66,280
+4,122% +$1.41M ﹤0.01% 1726
2019
Q4
$36K Sell
1,608
-1,021
-39% -$22.9K ﹤0.01% 2613
2019
Q3
$60K Buy
2,629
+1,021
+63% +$23.3K ﹤0.01% 2598
2019
Q2
$31K Buy
+1,608
New +$31K ﹤0.01% 1775